10-Year Trial Confirms Hydroxyurea Safe for Treating Children with Sickle Cell

A decade-long study conducted at four low-income sites in Africa has demonstrated that hydroxyurea is both effective and safe for treating children with sickle cell anemia. Importantly, the treatment did not lead to an increase in clinically diagnosed infections, supporting its use in resource-limited settings.

Originally published by gnews